PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 29 filers reported holding PROQR THRAPEUTICS N V in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $86,000 | -68.1% | 110,552 | +228.2% | 0.00% | – |
| Q4 2021 | $270,000 | +409.4% | 33,682 | +167.5% | 0.00% | – |
| Q4 2020 | $53,000 | -40.4% | 12,591 | -32.1% | 0.00% | – |
| Q3 2020 | $89,000 | -16.8% | 18,531 | +5.1% | 0.00% | – |
| Q2 2020 | $107,000 | -23.0% | 17,624 | -30.6% | 0.00% | – |
| Q1 2020 | $139,000 | -72.5% | 25,384 | -50.2% | 0.00% | -100.0% |
| Q4 2019 | $506,000 | +49.7% | 50,990 | +137.9% | 0.00% | – |
| Q4 2018 | $338,000 | -75.3% | 21,436 | -69.7% | 0.00% | -100.0% |
| Q3 2018 | $1,368,000 | +2300.0% | 70,686 | +506.1% | 0.00% | – |
| Q1 2016 | $57,000 | -74.1% | 11,663 | -54.0% | 0.00% | – |
| Q4 2015 | $220,000 | -51.2% | 25,376 | -17.9% | 0.00% | -100.0% |
| Q3 2015 | $451,000 | -30.6% | 30,921 | -20.7% | 0.00% | 0.0% |
| Q2 2015 | $650,000 | +87.9% | 38,993 | +146.7% | 0.00% | 0.0% |
| Q1 2015 | $346,000 | – | 15,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |